norepinephrine sintetica infusioonilahus
sintetica gmbh - norepinefriin (noradrenaliin) - infusioonilahus - 0,1mg 1ml 50ml 1tk
norepinephrine sintetica infusioonilahus
sintetica gmbh - norepinefriin (noradrenaliin) - infusioonilahus - 0,2mg 1ml 50ml 1tk
ephedrine sintetica süstelahus
sintetica gmbh - efedriin - süstelahus - 10mg 1ml 5ml 10tk
ephedrine sintetica süstelahus
sintetica gmbh - efedriin - süstelahus - 50mg 1ml 1ml 10tk
norepinephrine sintetica infusioonilahuse kontsentraat
sintetica gmbh - norepinefriin (noradrenaliin) - infusioonilahuse kontsentraat - 1mg 1ml 1ml 10tk; 1mg 1ml 5ml 10tk; 1mg 1ml 10ml 10tk
baclofen sintetica infusioonilahus
sintetica gmbh - baklofeen - infusioonilahus - 2mg 1ml 5ml 1tk; 2mg 1ml 20ml 1tk; 2mg 1ml 5ml 5tk
baclofen sintetica süstelahus
sintetica gmbh - baklofeen - süstelahus - 0,05mg 1ml 1ml 5tk
baclofen sintetica infusioonilahus
sintetica gmbh - baklofeen - infusioonilahus - 0,5mg 1ml 20ml 1tk
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmoloogilised vahendid - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
ezetimibe pharmaswiss tablett
pharmaswiss ceska republika s.r.o. - esetimiib - tablett - 10mg 10tk; 10mg 28tk; 10mg 20tk; 10mg 84tk; 10mg 50tk; 10mg 30tk; 10mg 300tk; 10mg 90tk; 10mg 98tk